...
首页> 外文期刊>Clinical Orthopaedics and Related Research >Human periosteum is a source of cells for orthopaedic tissue engineering: a pilot study.
【24h】

Human periosteum is a source of cells for orthopaedic tissue engineering: a pilot study.

机译:人骨膜是骨科组织工程的细胞来源:一项初步研究。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Periosteal cells are important in embryogenesis, fracture healing, and cartilage repair and could provide cells for osteochondral tissue engineering. QUESTIONS/PURPOSE: We determined whether a population of cells isolated from human periosteal tissue contains cells with a mesenchymal stem cell (MSC) phenotype and whether these cells can be expanded in culture and used to form tissue in vitro. METHODS: We obtained periosteal tissue from six patients. Initial expression of cell surface markers was assessed using flow cytometry. Cells were cultured over 10 generations and changes in gene expression evaluated to assess phenotypic stability. Phenotype was confirmed using flow cytometry and colony-forming ability assays. Mineral formation was assessed by culturing Stro-1(-) and unsorted cells with osteogenic supplements. Three cell culture samples were used for a reverse transcription-polymerase chain reaction, four for flow cytometry, three for colony-forming assay, and three for mineralization. RESULTS: Primary cultures, containing large numbers of hematopoietic cells were replaced initially by Stro-1 and ALP-expressing immature osteoblastic cell types and later by ALP-expressing cells, which lacked Stro-1 and which became the predominant cell population during subculture. Approximately 10% of the total cell population continued to express markers for Stro1(+)/ALP(-) cells throughout. CONCLUSIONS: These data suggest periosteum contains a large number of undifferentiated cells that can differentiate into neotissue and persist despite culture in noncell-specific media for over 10 passages. CLINICAL RELEVANCE: Cultured periosteal cells may contribute to tissue formation and may be applicable for tissue engineering applications.
机译:背景:骨膜细胞在胚胎发生,骨折愈合和软骨修复中很重要,可以为软骨组织工程化提供细胞。问题/目的:我们确定了从人骨膜组织分离的细胞群是否包含具有间充质干细胞(MSC)表型的细胞,以及这些细胞是否可以在培养中扩增并用于体外形成组织。方法:我们从6例患者中获得了骨膜组织。使用流式细胞术评估细胞表面标志物的初始表达。将细胞培养10代以上,并评估基因表达的变化以评估表型稳定性。使用流式细胞仪和集落形成能力测定法确认表型。通过与成骨补品一起培养Stro-1(-)和未分选的细胞来评估矿物质的形成。将三个细胞培养样品用于逆转录-聚合酶链反应,四个用于流式细胞仪,三个用于集落形成测定,三个用于矿化。结果:含有大量造血细胞的原代培养物最初被表达为Stro-1和ALP的未成熟成骨细胞类型所替代,后来被表达为ALP的细胞所替代,后者缺乏Stro-1,在继代培养中成为主要的细胞群。在整个细胞群体中,约有10%继续表达Stro1(+)/ ALP(-)细胞的标记。结论:这些数据表明骨膜含有大量未分化的细胞,尽管可以在非细胞特异性培养基中培养超过10代,但它们仍可以分化为新组织。临床意义:培养的骨膜细胞可能有助于组织形成,并可能适用于组织工程应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号